Embecta (EMBC) logo

Embecta (EMBC) stock

Diabetes devices , market cap $372M

$6.08
-1.78%

As of Tuesday's close · Live for Pro members at the open

Why is EMBC down?

Down 55% over three years while the S&P 500 rose 81%.

“The decrease in revenues was primarily driven by $20.1 million of unfavorable changes in price, $19.9 million of unfavorable changes in volume”

Embecta's Aug 7 release said

Sources: Price history, Nov 2, 2026; Company release, Aug 7, 2026

Tell me next time EMBC moves

Free account, no card. An optional alert when EMBC moves or its score changes.

Or see it live, free until Thursday morning. No account.
1 more reason, free with an account →5 more reasons why EMBC lags the market, from its filings, with the company's words and the timeline, for Pro members.
Quality Score
1
Below Average
In its industry
#59of 85

EMBC's Quality Score rose 1 point on Tue, Nov 3, to 1. Its 6-month gain rose to 56%, past 30%.

See EMBC's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on EMBC

Key facts on EMBC
Since its Dec 2022 highDown 83% profit $223.6M → $87.5M a year
Latest filing10-Q, Aug 7 Filed its quarterly report (10-Q) for the quarter to Jun 30, 2026
1 more reason behind EMBC's 1, free with an account →3 more reasons behind EMBC's 1, for Pro members.

EMBC catalysts

Coming up

After its last 4 reports it closed -11.6% on average, higher 1 of 4 times.

5 past catalysts since 2022, with sizes and sources, for Pro members.Get in free →

Why EMBC scores 1

Below Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means

  • +3Chart checks 3 of 14 firing right now, one point each
  • −3Long-term trend below a falling 200-⁠day average, down over one year, down over two years
  • Run-up adds
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Growth subtractsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • Insider trades adds

No effect today: Size, Dilution, Volatility, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on EMBC and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 8:56 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on EMBC and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

EMBC has 3 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on EMBC, and all 14 on every stock.Get in free →

EMBC RSI today: 48.1, above its 50-day, below its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

  • RSI 1448.1

    Above 30, below 50.

  • MACD (12, 26, 9)Below signal

    Crossed below its signal line 3 sessions ago.

  • The price is 5.2% above it.

  • The price is 4.6% below it.

  • 50/200 crossDeath cross

    The 50-day crossed below the 200-day on Jan 28.

  • ADX 1430.1

    25 or more, with +DI above -DI.

  • Support$5.49

    Swing low from Oct 2, 9.7% below the price.

  • Swing high from Oct 22, 13.5% above the price.

  • From Nov 12, 2025, 145.2% above the price.

  • From May 20, 54.4% below the price.

  • Chart patternRising channel

    Lines over the Sep 4 and Oct 22 highs and under the Jul 23 and Aug 6 lows.

  • The bands run from $5.66 to $6.96.

  • Volume0.7x

    Against its 20-day average, for the time of day.

The deep dive on EMBC

8 more findings on EMBC, each with its source, for Pro membersGet in free →

How EMBC ranks in Medical Devices

EMBC is #59 of 85 by Quality Score.

How EMBC ranks in Medical Devices
59Embecta (EMBC) logoEMBCEmbecta1

More in Medical Devices

When does EMBC report earnings, and what happens after?

Expected to report Wed Nov 25, before the open (in 22 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What EMBC reported on Aug 7, 2026

The quarter

The figures are not read from the release yet.

“The decrease in revenues was primarily driven by $20.1 million of unfavorable changes in price, $19.9 million of unfavorable changes in volume, and a $0.1 million decrease in contract manufacturing revenue.”

The filing on EDGAR

Where the sales came from

EMBC's results filing gives no sales by line in a table we read.

The outlook

No outlook figures read from this release.

The numbers

Market value
$372M
today
Sales
$1B
down 7.6% on the year
Free cash flow
$165M
last 12 months

Sales fell 0.1% a year over 5 years, fiscal 2020 to 2025.

Pays $0.32 a share a year.

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on EMBC: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →
ReportedGapReaction5
sessions
Aug 7, 2026Before open+18.3%+26.3%+46.0%
May 5, 2026Before open-45.2%-57.8%-63.7%
Feb 5, 2026Before open+11.1%-7.8%-11.4%

EMBC closed higher after 1 of its last 4 reports.

All 4 reports, and EMBC's Quality Score going into each

EMBC sales and profit by year

Sales and profit by year

Sales grew in two of the last five years, to $1.1B in 2025. It made a profit in each of the six years.

Is EMBC's dividend covered? What its financials say

Its dividends come to 11% of its free cash flow.

EMBC's dividend against its free cash flow
Dividend$0.32 a share a year Paid over the last year; the amount varies
Paid outAbout $18.1M a year $0.32 a share on 56.7M shares, the count on its cover page as of Jul 31, 2026
Free cash flow$165M The last four quarters, to Jun 30, 2026
RecordCut 93% Since May 2026

Insiders trading EMBC

EMBC insider trades

4 insiders bought $558K across 4 filings, and one insider sold $37K across 1 filing, in the last 6 months. The newest:

SellMilton Mayo Morris$37KDirectorat $5.88 on Sep 4, filed Sep 8
All 5 insider filings on EMBC from the last six months, for Pro members.Get in free →

All EMBC insider trades

EMBC trades by Congress and the executive branch

2 trades disclosed in the last six months. The newest:

SellDonald Trump$1K to $15KPresident (R)traded May 15, disclosed Jul 1(47 days later)
All 2 trades on EMBC disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

EMBC's officers and directors

Officers and directors with a Form 4 in the last 12 months.

4 more officers and directors file at EMBC. Each page above names the rest.

See insider trades by person

Which ETFs hold EMBC?

In ETFs: EMBC is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Embecta

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

1,850 employeesParsippany, NJembecta.com

What Embecta says it competes with

“The diabetes care industry is highly competitive, subject to rapid change and significantly affected by new product introductions and innovation.”

From its annual report, SEC filing · Nov 25, 2025

2 more sentences, what it says it does, and its sales by region, for Pro membersGet in free →

EMBC's score card

Embecta (EMBC): Quality Score 1, Below Average, #59 of 85 in Medical Devices, with its price, on Breakaway
The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

  • What would turn EMBC's score around: 6 things
  • 1 more filing explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayJul 1Donald Trump bought EMBC$15K to $50K, disclosed Jul 1

Alerts are optional.

See EMBC's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 3, 2026: EMBC's Quality Score is 1 (Below Average), #59 of 85 in Medical Devices. Insiders bought $558K and sold $37K in the last 6 months (Form 4).

Is EMBC a good stock to buy? What its Quality Score says

EMBC scores 1 today, which Breakaway calls Below Average. It is #59 of 85 in Medical Devices by Quality Score, with 3 of 14 chart checks firing. Down 55% over three years while the S&P 500 rose 81%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is EMBC's Quality Score?

EMBC scores 1 today, which Breakaway calls Below Average (0 to 5). That is #59 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind EMBC's 1.

Are insiders buying EMBC?

4 insiders bought $558K across 4 filings, and one insider sold $37K across 1 filing, in the last 6 months. The newest is Milton Mayo Morris, Director, who sold $37K on Sep 4. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The moves after past earnings reports are past behavior, not a forecast.

The dividend's cover: free cash flow and shares from its SEC filings; the dividend from its regular payouts over six years.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.